Employees: 3,592
Size IOL Chemicals & Pharmaceuticals (IOLCP.NS) is an India Materials company (Chemicals: Specialty) with a market value of $596M, the 786th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹189.74 on 18 Nov 2026.
Performance Over six months the shares gained 72.3%, against -30.4% for the median peer and +3.8% for the India market (cap-weighted) — 2nd highest of 20 in its peer set.
Growth Revenue grew 26.8% over the last twelve months (peer median +19.5%); the operating margin is 10.1% (peer median 8.1%).
Valuation It trades at 22.3× forward earnings against a peer median of 11.6× (5th most expensive of 12).
Price implies For today's price to make sense, revenue must grow about 27% a year for seven years (Req g). Recent delivered growth is +3%, so the hurdle is +24 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 3.7 points below its cost of capital (14.2% WACC).
Next results Next results expected around 9 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹27.5B | ₹23.1B | ₹20.7B | ₹21.2B | ₹22.1B |
| Revenue growth | — | +12% | -2% | -4% | — |
| Gross profit | ₹6.66B | ₹2.89B | ₹2.34B | ₹2.70B | ₹2.75B |
| EBITDA | ₹3.63B | ₹2.63B | ₹1.96B | ₹2.23B | ₹2.20B |
| Net income | ₹2.03B | ₹1.38B | ₹1.01B | ₹1.34B | ₹1.39B |
| Free cash flow | n/a | ₹384M | -₹374M | ₹130M | -₹882M |
| Capital expenditure | n/a | ₹1.73B | ₹2.14B | ₹2.74B | ₹2.12B |
| Total debt | ₹2.01B | ₹1.35B | ₹1.17B | ₹328M | ₹798M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | IOLCP.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +3.6% | -11.1% | 5th highest of 21 |
| 6-month return | +72.3% | -30.4% | 2nd highest of 20 |
| Distance from 52-week high | -15.3% | -52.8% | 4th highest of 21 |
| Revenue growth (TTM) | +26.8% | +19.5% | 9th highest of 21 |
| Operating margin | 10.1% | 8.1% | 10th highest of 20 |
| Forward P/E | 22.3× | 11.6× | 5th most expensive of 12 |
| Growth the price implies (Req g, 7 yrs) | 27.1% | 7.2% | 4th most demanding of 12 |
| Growth delivered (Del g) | +3.5% | +6.9% | 5th lowest of 11 |
| Hurdle (Req g minus delivered) | +23.7 pp | +2.1 pp | 2nd most demanding of 11 |
| ROIC minus cost of capital | -3.7 pp | -0.7 pp | 7th lowest of 20 |
| EV / EBITDA | 15.5× | 6.2× | 2nd most expensive of 7 |
| Net debt / EBITDA | 0.2× | -0.7× | 2nd most indebted of 7 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| IOL Chemicals & Pharmaceuticals IOLCP.NS | India | $596M | +72% | +27% | 10% | 22.3× | 27.1% | +3.5% |
| Pan Asian Microvent Tech (Jiangsu) 688386.SS | China | $598M | -50% | +12% | 15% | 36.6× | n/a | n/a |
| Hangzhou Gaoxin Materials Technology 300478.SZ | China | $600M | -21% | -21% | -9% | n/a | 29.9% | -0.9% |
| Jiangsu Lopal Tech 2465.HK | Hong Kong | $590M | -61% | +107% | 7% | 4.8× | n/a | n/a |
| Cybrid Technologies 603212.SS | China | $588M | -40% | -9% | -7% | 162.9× | n/a | n/a |
| Jiangsu Baichuan High-Tech New Materials 002455.SZ | China | $604M | -43% | +9% | 1% | n/a | n/a | n/a |
| Renxin New Material 301395.SZ | China | $587M | +13% | +1% | -6% | n/a | n/a | n/a |
| Zhejiang Jiaao Enprotech Stock 603822.SS | China | $585M | -27% | +101% | 19% | 7.9× | -9.8% | +31.6% |
| LOTTE Fine Chem 004000.KS | South Korea | $610M | -45% | +18% | 7% | 4.3× | -20.1% | +6.8% |
| Dainichiseika Color & Chemicals Mfg.Co 4116.T | Japan | $610M | +23% | +5% | 8% | n/a | 1.8% | -2.1% |
| MEC 4971.T | Japan | $582M | -52% | +31% | 32% | 14.7× | 16.1% | +11.9% |
| Hangzhou Grascent 301688.SZ | China | $613M | n/a | +12% | n/a | n/a | 42.9% | n/a |
| Miracll Chemicals 300848.SZ | China | $578M | -46% | +23% | 1% | 11.1× | n/a | n/a |
| Hubei Hongyuan Pharmaceutical Technology 301246.SZ | China | $576M | -57% | +45% | 12% | n/a | n/a | n/a |
| Cytech 301557.SZ | China | $619M | -1% | +13% | 7% | n/a | n/a | n/a |
| DKS 4461.T | Japan | $573M | +3% | +31% | 15% | 9.5× | 7.2% | +7.0% |
| Formosan Union Chemical 1709.TW | Taiwan | $619M | +159% | +14% | 41% | n/a | -17.9% | +1.2% |
| Advanced Nano Products 121600.KS | South Korea | $572M | -11% | +33% | 12% | 47.1× | 27.9% | +18.2% |
| Argus (Shanghai) Textile Chemicals 603790.SS | China | $572M | -30% | +21% | 14% | n/a | 10.6% | +0.7% |
| Anhui Estone Materials Technology 688733.SS | China | $622M | -43% | +52% | -2% | 47.7× | n/a | n/a |
| Tidewater Renewables LCFS.TO | Canada | $567M | +71% | +103% | 25% | 11.6× | -12.6% | +126.4% |